Koya Medical Honored by Goldman Sachs for Entrepreneurship
Koya Medical CEO Andy Doraiswamy Among the Most Exceptional Entrepreneurs at 2025 Builders and Innovators Summit
Today, Goldman Sachs (NYSE:GS) is recognizing Koya Medical (“Koya”) CEO Andy Doraiswamy, PhD as one of the Most Exceptional Entrepreneurs of 2025 at its Builders and Innovators Summit in Healdsburg, California.
Goldman Sachs selected Koya CEO Andy Doraiswamy from multiple industries to be honored at the two-day event. He enjoys bringing bold, loving, and innovative teams together to enable health and access across our planet. Previously, he led key developments in ophthalmology with innovations including sight-restoring intraocular implants that have given sight to more than 10 million humans across the globe. This technology was acquired by Santen Pharmaceutical Co., Ltd and is currently marketed by Bausch + Lomb (marketed as enVista® IOL). He trained as a scientist with a specialization in biomedical applications to solve diseases and extend healthy human life.
